wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38669565-F9A20A6A-6203-45CA-A97C-955AAE087E4A
Q38669565-F9A20A6A-6203-45CA-A97C-955AAE087E4A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38669565-F9A20A6A-6203-45CA-A97C-955AAE087E4A
A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
P2860
Q38669565-F9A20A6A-6203-45CA-A97C-955AAE087E4A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38669565-F9A20A6A-6203-45CA-A97C-955AAE087E4A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
420bf394a7dacf383a94098f8ee4c520c360c0bb
P2860
Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist.